Influenza virus reassortant vaccine candidates (6:2)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Influenza virus reassortant vaccine candidates (6:2), covering 2014-02-03 to 2014-02-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults [Phase 4]